The National Drug Early Warning System (NDEWS) Naloxone Phase II Replication Studies were designed to explore the feasibility of rapidly addressing timely research questions by adding questions to ongoing studies already in the field. Information about the awareness and availability of naloxone, attitudes towards naloxone, and naloxone’s influence on drug use was collected from a local (Baltimore, MD) and a national (Researched Abuse, Diversion and Addiction-Related Surveillance [RADARS®] System) sample of persons seeking treatment for opioid use disorder (OUD). A smaller, Phase I study formed the basis for the Phase II replication studies.
Second round studies:
Characterizing Knowledge, Attitudes, Behaviors, and Practices Related to Bystander Naloxone in Methadone-Maintained Individuals with Opioid Use Disorder
Annabelle M. Belcher, PhD, Thomas O. Cole, MA, Mark Yoon, MA, Alexander Pappas, MD, Zofia Kozak, MD, Christopher Welsh, MD, Eleanor Erin Artigiani, MA, Eric D. Wish, PhD
A Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System Report: RADARS® System Treatment Center Programs Combined Study of Naloxone Experiences and Attitudes
Stevan Geoffrey Severtson, Marie Gurrola, David Grundy, Heather Olsen, Janetta Iwanicki
First round studies:
Nobody Wants to Be Narcan’d: A Pilot Qualitative Analysis of Drug Users’ Perspectives on Naloxone
Quick turnaround substudies on naloxone in three cities (2019): Cleveland, Ohio; Worcester, Massachusetts; Baltimore, Maryland.
- Webinar: Perceptions of Naloxone Among Urban Opioid Users in 3 Cities (10/29/2019)
Jeffrey T. Lai, MD, Charlotte Goldfine, MD, Brittany P. Chapman, BSc, Melissa M. Taylor, BA, Rochelle K. Rosen, Ph.D., Stephanie P. Carreiro, MD, and Kavita M. Babu, MD